Technoderma Medicines Inc.

Quick facts

Phase 2 pipeline

• TDM-105795, 0.0025%
• TDM-105795, 0.02%
• TDM-180935 topical ointment 1.0%
• TDM-180935 topical ointment 2.0%

Phase 1 pipeline

• TDM-105795
• TDM-180935

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Technoderma Medicines Inc. portfolio CI brief
• Technoderma Medicines Inc. pipeline updates RSS